MCO Molecular and Clinical Oncology 2049-9450 2049-9469 D.A. Spandidos 10.3892/mco.2017.1315 MCO-0-0-1315 Corrigendum High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review YamamotoEiko NiimiKaoru FujikakeKayo NishidaTetsuya MurataMakoto MitsumaAyako AndoYuichi KikkawaFumitaka 09 2017 30 06 2017 7 3 510 510 Copyright: © Yamamoto et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Mol Clin Oncol 5: 660-664, 2016; DOI: 10.3892/mco.2016.1011

Following the publication of the article, the authors noticed the following error: In Table I, the dose of Ifosfamide in mini ICE regimen should be 1,000 mg/m2 instead of 2,000 mg/m2. This had occurred due to a typing error on behalf of the authors upon submission. Shown below is the new version of Table I:

In addition, the authors noted that the concentration unit of G-CSF mentioned on page 661 should be µg/kg/day instead of mg/m2/day or g/kg/day.

Mini and high-dose ifosfamide, carboplatin and etoposide (ICE) regimens.

Agents Dose Hours Days
Mini ICE
  Ifosfamide 1,000 mg/m2 d.i.v.   1 1–2
  Etoposide   150 mg/m2 d.i.v. 11 1–2
  Carboplatin   200 mg/m2 d.i.v.   1 1–2
  Etoposide   150 mg/m2 d.i.v. 11 1–2
High-dose ICE
  Ifosfamide 3,000 mg/m2 d.i.v.   1 1–4
  Etoposide   200 mg/m2 d.i.v. 11 1–3
  Carboplatin   300 mg/m2 d.i.v.   1 1–4
  Etoposide   200 mg/m2 d.i.v. 11 1–3

d.i.v., drip intravenous infusion.